NFA
PACB icon

Nationwide Fund Advisors’s Pacific Biosciences PACB Stock Holding History

Nationwide Fund Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-54,403
Closed -$286K – 1487
2017
Q3 		$286K Buy
54,403
+7,861
+17% +$33.8K ﹤0.01% 2457
2017
Q2 		$166K Hold
46,542
– – ﹤0.01% 2706
2017
Q1 		$241K Sell
46,542
-3,763
-7% -$18.4K ﹤0.01% 2501
2016
Q4 		$191K Sell
50,305
-515
-1% -$3.74K ﹤0.01% 2626
2016
Q3 		$455K Buy
50,820
+1,063
+2% +$8.88K ﹤0.01% 2221
2016
Q2 		$350K Buy
49,757
+8,617
+21% +$78.7K ﹤0.01% 2336
2016
Q1 		$377K Buy
41,140
+2,534
+7% +$24.9K ﹤0.01% 2236
2015
Q4 		$507K Buy
38,606
+713
+2% +$6.4K ﹤0.01% 2111
2015
Q3 		$139K Sell
37,893
-2,183
-5% -$10.7K ﹤0.01% 2760
2015
Q2 		$231K Sell
40,076
-2,558
-6% -$14.8K ﹤0.01% 2639
2015
Q1 		$249K Sell
42,634
-37,600
-47% -$259K ﹤0.01% 2583
2014
Q4 		$629K Buy
80,234
+3,149
+4% +$20.1K ﹤0.01% 2049
2014
Q3 		$378K Buy
77,085
+433
+0.6% +$2.26K ﹤0.01% 2364
2014
Q2 		$474K Buy
76,652
+6,574
+9% +$32.9K ﹤0.01% 2290
2014
Q1 		$375K Sell
70,078
-78,539
-53% -$496K ﹤0.01% 2196
2013
Q4 		$777K Buy
148,617
+5,138
+4% +$23.6K ﹤0.01% 2014
2013
Q3 		$793K Buy
143,479
+105,980
+283% +$368K ﹤0.01% 1969
2013
Q2 		$94K Buy
+37,499
New +$93.4K ﹤0.01% 2825

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Nationwide Fund Advisors's PACB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Pacific Biosciences (PACB) in Q4 2017, closing a stake of 54,403 shares — an estimated $286K sold.

Nationwide Fund Advisors first reported a position in PACB in Q2 2013 and held it in 18 quarters. The position peaked at $793K in Q3 2013. 109 funds tracked by Wall St. Rank hold PACB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Pacific Biosciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 54,403 Pacific Biosciences shares in Q4 2017, an estimated $286K.
  • Nationwide Fund Advisors first reported a position in Pacific Biosciences in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Pacific Biosciences position peaked at $793K in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.